Truist Securities expressed a positive outlook on Boston Scientific (NYSE:BSX) shares, raising the price target to $120 from $110, while reaffirming a Buy rating. The stock, currently trading near its ...

Wedbush restated their outperform rating on shares of Scholar Rock (NASDAQ:SRRK – Free Report) in a research note published on Wednesday,RTT News reports. They currently have a $47.00 target price on ...

If you don’t qualify for the best cash offers this month — and most will not — we’ve included the 5 most accessible sign-up ...

This quarter, we're planning to activate our largest wave of platforms yet so that by the end of March, more than half of our people will be working in the model. We believe that our transition ...

Shares of Scholar Rock Holding Co. (NASDAQ:SRRK – Get Free Report) have received an average recommendation of “Buy” from the seven brokerages that are covering the firm, MarketBeat reports. Six ...

“So, I waited seven to 10 days, and whenever I got my new card, it wouldn’t let me into the Truist banking app to activate it.” Jennings said she has used Truist for more than two years and ...

If you want a higher tier travel credit card, you might consider a card that charges an annual fee that's lower than the credit it offers for TSA PreCheck, Global Entry or Nexus. While you technically ...

In a new research note, Truist said the FDA labelling is "largely as we expected [and] a favourable nod from the FDA" and could speed up the activation of new centres and patient onboarding time.

Truist upgraded the stock to “Buy” from Hold, boosting the price target to $300 from $250. According to the firm, there is “still room for upside from here” for Atlassian. The analysts ...

In a report released today, William Stein from Truist Financial maintained a Buy rating on TTM Technologies (TTMI – Research Report). The ...

UBS analyst Erika Najarian raised the firm’s price target on Truist Financial (TFC) to $53 from $50 and keeps a Buy rating on the shares. The ...